Radiolabeled Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoma

This publication has 52 references indexed in Scilit:

• CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
  New England Journal of Medicine, 2002
• Radioimmunotherapy with Iodine-131 Tositumomab in Patients with Low-Grade Non-Hodgkin's B-Cell Lymphoma Does Not Induce Loss of Acquired Humoral Immunity against Common Antigens
  Clinical Immunology, 2001
• Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-α2a) plus an anthracycline-based induction regimen
  Leukemia, 2001
• Correlation of marrow dose estimates based on serial pretreatment radiopharmaceutical imaging and blood data with actual marrow toxicity in anti-CD20 yttrium-90 monoclonal antibody radioimmunotherapy of non-Hodgkinʼs B-cell lymphoma
  Nuclear Medicine Communications, 2001
• Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation
  Blood, 2001
• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• Tumor-Absorbed-Dose Estimates versus Response in Tositumomab Therapy of Previously Untreated Patients with Follicular non-Hodgkin's Lymphoma: Preliminary Report
  Cancer Biotherapy & Radiopharmaceuticals, 2000
• Human Anti-Mouse Antibody Response in Cancer Patients Following Single Low-Dose Injections of Radiolabeled Murine Monoclonal Antibodies
  Cancer Biotherapy, 1994
• Recombinant Interferon Alfa-2b Combined with a Regimen Containing Doxorubicin in Patients with Advanced Follicular Lymphoma
  New England Journal of Medicine, 1993
• Cancer Risk After Iodine-131 Therapy for Hyperthyroidism
  JNCI Journal of the National Cancer Institute, 1991